Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Chun

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Acta Haematologica|January 1, 1994
Incidence and treatment of tumor lysis syndrome in patients with acute leukemiaE Razis, Z A Arlin, T Ahmed, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 7, 1999
Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillationD W Sohn, J M Song, J H Zo, et al.
Cancer Research|April 1, 1991
Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tubeF T Ward, J A Kelley, J S Roth, et al.
Leukemia & Lymphoma|July 27, 2016
Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion ScheduleS M Lichtman, A Mittelman, D R Budman, et al.
Cancer|September 15, 1991
Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemiaZ A Arlin, E J Feldman, A Mittelman, et al.
Investigational New Drugs|February 1, 1993
Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trialsJ S Fisherman, B L Osborn, H G Chun, et al.
Cancer Treatment Reports|August 1, 1986
Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agentH G Chun, B Leyland-Jones, D Hoth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1992
Patient treatment on a compassionate basis: documentation of high adverse drug reaction rateB Leyland-Jones, B R Davies, K Clagett-Carr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council studyP J Stiff, R S McKenzie, L D Potempa, et al.
Bone Marrow Transplantation|June 1, 2000
High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcomeT Ahmed, R Kancherla, Z Qureshi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Acta Haematologica|January 1, 1994
Incidence and treatment of tumor lysis syndrome in patients with acute leukemiaE Razis, Z A Arlin, T Ahmed, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 7, 1999
Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillationD W Sohn, J M Song, J H Zo, et al.
Cancer Research|April 1, 1991
Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tubeF T Ward, J A Kelley, J S Roth, et al.
Leukemia & Lymphoma|July 27, 2016
Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion ScheduleS M Lichtman, A Mittelman, D R Budman, et al.
Cancer|September 15, 1991
Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemiaZ A Arlin, E J Feldman, A Mittelman, et al.
Investigational New Drugs|February 1, 1993
Chloroquinoxaline sulfonamide: a sulfanilamide antitumor agent entering clinical trialsJ S Fisherman, B L Osborn, H G Chun, et al.
Cancer Treatment Reports|August 1, 1986
Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agentH G Chun, B Leyland-Jones, D Hoth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1992
Patient treatment on a compassionate basis: documentation of high adverse drug reaction rateB Leyland-Jones, B R Davies, K Clagett-Carr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council studyP J Stiff, R S McKenzie, L D Potempa, et al.
Bone Marrow Transplantation|June 1, 2000
High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcomeT Ahmed, R Kancherla, Z Qureshi, et al.
Pageof 3